|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.
The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by Morgan Stanley on May 7, 2021. The analyst firm set a price target for 495.00 expecting REGN to fall to within 12 months (a possible -5.81% downside). 34 analyst firms have reported ratings in the last year.
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $525.55 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Regeneron Pharmaceuticals.
There is no upcoming split for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.